A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)
Astellas Pharma Inc
Astellas Pharma Inc
Incyte Corporation
Pfizer
Pfizer
University of Virginia
Exelixis
Kinnate Biopharma
Molecular Templates, Inc.
Inhibrx Biosciences, Inc
Taris Biomedical LLC
Pfizer
Kyowa Kirin Co., Ltd.
University of Florida
Fate Therapeutics
AvenCell Therapeutics, Inc.
Advaxis, Inc.
Genocea Biosciences, Inc.
Augusta University
Principia Biopharma, a Sanofi Company
University of Utah
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center